Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
WLFI, the Trump Family's Crypto Project, Refutes U.S. Senator's Investigation into USD1's Ties with Trump

WLFI, the Trump Family's Crypto Project, Refutes U.S. Senator's Investigation into USD1's Ties with Trump

Odaily星球日报Odaily星球日报2025/05/16 12:29
Show original
The Trump family's cryptocurrency project, World Liberty Financial (WLFI), has responded to an investigation by U.S. Senate Democrat Richard Blumenthal regarding the relationship between its USD1 stablecoin and former President Trump. The project's lawyer stated that the investigation is politically motivated. World Liberty Financial emphasized that the USD1 stablecoin is backed by the U.S. dollar and U.S. Treasury bonds, operates transparently, and complies with regulatory requirements. Previously, U.S. Senate Democrats expressed concerns about the connections between World Liberty Financial and the Trump family, pointing out a potential conflict of interest in the company's $2 billion investment agreement with Abu Dhabi state-owned enterprise MGX. World Liberty Financial stated that its operations are independent of the Trump administration and that all investments follow compliance procedures. (The Block)
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks